CMS opens door for PET coverage for oncologic uses

03/9/2013 | HealthImaging.com · MedPage Today (free registration)

CMS has lifted the non-coverage decision for PET imaging for oncologic procedures, allowing local Medicare administrators to make decisions about coverage. The ruling, however, does not apply to cardiac and neurologic uses. SNMMI and other groups had lobbied for a broader decision. The decision applies to use of C-11 choline and other PET imaging agents for oncologic applications. The ruling does not address PET agents FDG, NaF-18, ammonia N-13 and rubidium-82, which already have been addressed with coverage determinations.

View Full Article in:

HealthImaging.com · MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX